Holocene Advisors LP Takes $58.32 Million Position in Henry Schein, Inc. (NASDAQ:HSIC)

Holocene Advisors LP purchased a new stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 799,981 shares of the company’s stock, valued at approximately $58,319,000. Holocene Advisors LP owned about 0.64% of Henry Schein at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the business. Cromwell Holdings LLC raised its holdings in shares of Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after buying an additional 170 shares during the last quarter. Studio Investment Management LLC increased its stake in shares of Henry Schein by 3.8% during the third quarter. Studio Investment Management LLC now owns 4,674 shares of the company’s stock valued at $341,000 after acquiring an additional 172 shares during the period. Simplify Asset Management Inc. increased its stake in shares of Henry Schein by 5.0% during the second quarter. Simplify Asset Management Inc. now owns 3,695 shares of the company’s stock valued at $237,000 after acquiring an additional 175 shares during the period. Sequoia Financial Advisors LLC increased its stake in shares of Henry Schein by 3.2% during the second quarter. Sequoia Financial Advisors LLC now owns 5,680 shares of the company’s stock valued at $364,000 after acquiring an additional 176 shares during the period. Finally, Mather Group LLC. increased its stake in shares of Henry Schein by 16.8% during the second quarter. Mather Group LLC. now owns 1,502 shares of the company’s stock valued at $96,000 after acquiring an additional 216 shares during the period. Institutional investors own 96.62% of the company’s stock.

Henry Schein Trading Down 0.7 %

Henry Schein stock opened at $76.50 on Tuesday. The company has a 50 day moving average price of $71.57 and a 200 day moving average price of $69.88. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.63. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The firm has a market capitalization of $9.54 billion, a price-to-earnings ratio of 31.48, a P/E/G ratio of 2.21 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. During the same quarter last year, the business posted $1.32 EPS. The company’s revenue was up .4% on a year-over-year basis. Research analysts forecast that Henry Schein, Inc. will post 4.78 EPS for the current year.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the sale, the senior vice president now owns 71,833 shares of the company’s stock, valued at $4,978,026.90. This trade represents a 22.65 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, COO Michael S. Ettinger sold 12,240 shares of Henry Schein stock in a transaction on Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the sale, the chief operating officer now directly owns 87,706 shares of the company’s stock, valued at $6,577,950. This trade represents a 12.25 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently commented on HSIC shares. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. UBS Group lowered their price objective on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 7th. JPMorgan Chase & Co. lowered their price objective on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research note on Monday, August 12th. Robert W. Baird decreased their price target on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 7th. Finally, Evercore ISI lifted their price target on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Six investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Henry Schein has an average rating of “Moderate Buy” and a consensus price target of $79.38.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.